StockData

Albemarle vs Eastman Chemical

ALB and EMN side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ALB and EMN compare

Albemarle is the larger company, worth 1.4 times as much as Eastman Chemical ($10.4B against $7.3B).

On earnings, Eastman Chemical is cheaper: it trades at 11.7× trailing earnings, against 327× for Albemarle.

Albemarle grew revenue faster over the last twelve months (18.3% versus 0.27% for Eastman Chemical).

Eastman Chemical keeps more of each dollar of sales as profit, with a net margin of 6.9% compared with 3.8% at Albemarle.

Both pay dividends: Albemarle yields 1.8% and Eastman Chemical 5.3%.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricALBEMN
Size and price
Market cap$10.4B$7.3B
Share price$88.16$63.49
Change, 1 year−23.1%1.2%
Change, 5 years−67.0%−42.5%
Beta (5Y)1.340.53
Employees7,80013K
StockData Score
Total score1616
Valuation score45 (better)
Growth score3 (better)1
Performance score12 (better)
Health score4 (better)2
Dividend score46 (better)
Valuation
P/E327×11.7× (better)
P/S1.8×0.8× (better)
P/B1.0× (better)1.2×
EV/EBITDA12.2×–
P/FCF7.7× (better)15.5×
FCF yield12.9% (better)6.5%
Fair value$118.94$94.88
Margin of safety25.9%33.1% (better)
Growth
Revenue growth (TTM)18.3% (better)0.27%
Revenue growth, 5Y average10.4% (better)0.65%
Net income growth (TTM)–−13.3%
EPS growth (TTM)–−12.3%
EPS growth, 5Y average–3.2%
Profitability
Gross margin23.8% (better)20.6%
Operating margin4.3%–
Net margin3.8%6.9% (better)
FCF margin22.7% (better)5.2%
Return on equity2.2%10.4% (better)
Return on invested capital1.1%–
Financial health
Debt / equity0.18 (better)0.83
Net debt / EBITDA0.27–
Current ratio2.09 (better)1.57
Altman Z-score2.20 (better)2.12
Piotroski F-score6 (better)5
Dividends and buybacks
Dividend yield1.8%5.3% (better)
Payout ratio85.0%61.1%
Years of dividend growth1616
Dividend growth, 5Y average1.0%4.5% (better)
Shareholder yield1.8%5.3% (better)
Ownership
Held by institutions98.3%94.1%
Held by insiders0.35%0.83%
Insider net buying, 12 months−$7.4M−$206K (better)
Superinvestors holding–1
Short interest, % of float10.5%4.9%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.